CVS Health Corp. buy Royal Bank of Canada
Summary
This prediction ended on 04.08.24 with a price of €53.88. The price of CVS Health Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.18%. Royal_Bank_of_Canada has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Dividends of €2.42 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -1.527% | -1.527% | 29.360% |
| iShares Core DAX® | -0.230% | -0.593% | 24.694% |
| iShares Nasdaq 100 | -1.780% | 6.137% | 12.735% |
| iShares Nikkei 225® | -2.684% | 9.665% | 20.259% |
| iShares S&P 500 | -0.694% | 4.771% | 6.667% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.
Current prediction by Royal_Bank_of_Canada for CVS Health Corp.
Stopped prediction by Royal_Bank_of_Canada for CVS Health Corp.
CVS Health Corp.
08.02.24
08.02.25
09.02.25
CVS Health Corp.
18.08.23
18.08.24
19.08.24